The gut microbiome plays a significant role in modulating the immune system and influencing inflammation, both of which are critical in cancer development and progression. Researchers are exploring how FMT can influence cancer treatment outcomes, particularly in enhancing the efficacy of immunotherapy. Emerging studies suggest that a diverse and balanced gut microbiota may enhance the body's response to cancer therapies.
